The Imaging Genetic Study of Schizophrenia and Family

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Kunming Medical University
Sponsor:
Collaborator:
Chinese Academy of Sciences
Information provided by (Responsible Party):
Yuqi Cheng, Kunming Medical University
ClinicalTrials.gov Identifier:
NCT01259232
First received: December 10, 2010
Last updated: March 19, 2014
Last verified: March 2014
  Purpose

To investigate the brain abnormalities and the association with gene in schizophrenia patients and their relatives.


Condition
Schizophrenia

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by Kunming Medical University:

Primary Outcome Measures:
  • the association between gene and fMRI in schizophrenia patients [ Time Frame: 30 days after diagnosis ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: September 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
schizophrenia patients,untreated
schizophrenia relatives
controls

  Eligibility

Ages Eligible for Study:   15 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

schizophrenia patients and their relatives

Criteria

Inclusion Criteria:

  • Clinical diagnosis of schizophrenia(DSM-IV)
  • total score of PANSS>64

Exclusion Criteria:

  • other psychiatric disease,
  • organic disease
  • neurological disease
  • unstable physiological status
  • age>65
  • pregnant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01259232

Contacts
Contact: Yuqi Cheng 8613888122013 yuqich@163.com
Contact: Xiufeng Xu xfxu2004@sina.com

Locations
China, Yunnan
Psychiatry department, The 1st Affiliated Hospital of Kunming Medical University Recruiting
Kunming, Yunnan, China, 650032
Contact: Xiufeng Xu       xfxu2004@sina.com   
Sponsors and Collaborators
Kunming Medical University
Chinese Academy of Sciences
Investigators
Study Director: Xiufeng Xu Psychiatry Department
  More Information

No publications provided

Responsible Party: Yuqi Cheng, Kunming Medical University
ClinicalTrials.gov Identifier: NCT01259232     History of Changes
Other Study ID Numbers: SCH001, KMC2010L4
Study First Received: December 10, 2010
Last Updated: March 19, 2014
Health Authority: China: Ethics Committee

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on August 28, 2014